Page 129 - Read Online

Luo et al. Microbiome Res Rep 2025;4:10 https://dx.doi.org/10.20517/mrr.2024.57 Page 19 of 25

colorectal neoplasia. Nat Commun 2024;15:646. DOI PubMed PMC
10. Britton RA, Hoffmann DE, Khoruts A. Probiotics and the microbiome-how can we help patients make sense of probiotics?
Gastroenterology 2021;160:614-23. DOI PubMed
11. Yadav AK, Tyagi A, Kumar A, et al. Adhesion of Lactobacilli and their anti-infectivity potential. Crit Rev Food Sci Nutr
2017;57:2042-56. DOI PubMed
12. Breukink E, Wiedemann I, van Kraaij C, Kuipers OP, Sahl HG, de Kruijff B. Use of the cell wall precursor lipid II by a pore-forming
peptide antibiotic. Science 1999;286:2361-4. DOI PubMed
13. Hols P, Ledesma-García L, Gabant P, Mignolet J. Mobilization of microbiota commensals and their bacteriocins for therapeutics.
Trends Microbiol 2019;27:690-702. DOI PubMed
14. Tiwari SK. Bacteriocin-producing probiotic lactic acid bacteria in controlling dysbiosis of the gut microbiota. Front Cell Infect
Microbiol 2022;12:851140. DOI PubMed PMC
15. Bender MJ, McPherson AC, Phelps CM, et al. Dietary tryptophan metabolite released by intratumoral Lactobacillus reuteri facilitates
immune checkpoint inhibitor treatment. Cell 2023;186:1846-62.e26. DOI PubMed PMC
16. Martin FP, Cominetti O, Berger B, et al. Metabolome-associated psychological comorbidities improvement in irritable bowel
syndrome patients receiving a probiotic. Gut Microbes 2024;16:2347715. DOI PubMed PMC
17. Srivastava S, Basak U, Naghibi M, et al. A randomized double-blind, placebo-controlled trial to evaluate the safety and efficacy of
live Bifidobacterium longum CECT 7347 (ES1) and heat-treated Bifidobacterium longum CECT 7347 (HT-ES1) in participants with
diarrhea-predominant irritable bowel syndrome. Gut Microbes 2024;16:2338322. DOI PubMed PMC
18. Zhang Q, Li G, Zhao W, et al. Efficacy of Bifidobacterium animalis subsp. lactis BL-99 in the treatment of functional dyspepsia: a
randomized placebo-controlled clinical trial. Nat Commun 2024;15:227. DOI PubMed PMC
19. Han Y, Zhou Y, Xu X, et al. Improvement of post-surgery constipation in patients with fractures by Lactobacillus rhamnosus JYLR-
127: a single-blind randomized controlled trial. Nutrients 2024;16:1505. DOI PubMed PMC
20. Koyama S, Fujita H, Shimosato T, et al; Yokohama Cooperative Study Group for Hematology (YACHT). Septicemia from
Lactobacillus rhamnosus GG, from a probiotic enriched yogurt, in a patient with autologous stem cell transplantation. Probiotics
Antimicro Prot 2019;11:295-8. DOI
21. Rossi F, Amadoro C, Gasperi M, Colavita G. Lactobacilli infection case reports in the last three years and safety implications.
Nutrients 2022;14:1178. DOI PubMed PMC
22. Kassam Z, Dubois N, Ramakrishna B, et al. Donor screening for fecal microbiota transplantation. N Engl J Med 2019;381:2070-2.
DOI
23. Nasrollahzadeh A, Mokhtari S, Khomeiri M, Saris PEJ. Antifungal preservation of food by lactic acid bacteria. Foods 2022;11:395.
DOI PubMed PMC
24. Zuo F, Zeng Z, Hammarström L, Marcotte H. Inducible plasmid self-destruction (IPSD) assisted genome engineering in lactobacilli
and bifidobacteria. ACS Synth Biol 2019;8:1723-9. DOI PubMed
25. Bober JR, Beisel CL, Nair NU. Synthetic biology approaches to engineer probiotics and members of the human microbiota for
biomedical applications. Annu Rev Biomed Eng 2018;20:277-300. DOI PubMed PMC
26. Wu J, Xin Y, Kong J, Guo T. Genetic tools for the development of recombinant lactic acid bacteria. Microb Cell Fact 2021;20:118.
DOI PubMed PMC
27. Seyedian SS, Nokhostin F, Malamir MD. A review of the diagnosis, prevention, and treatment methods of inflammatory bowel
disease. J Med Life 2019;12:113-22. DOI PubMed PMC
28. Kaplan GG. The global burden of IBD: from 2015 to 2025. Nat Rev Gastroenterol Hepatol 2015;12:720-7. DOI PubMed
29. Alipour M, Zaidi D, Valcheva R, et al. Mucosal barrier depletion and loss of bacterial diversity are primary abnormalities in
paediatric ulcerative colitis. J Crohns Colitis 2016;10:462-71. DOI PubMed PMC
30. Danne C, Skerniskyte J, Marteyn B, Sokol H. Neutrophils: from IBD to the gut microbiota. Nat Rev Gastroenterol Hepatol
2024;21:184-97. DOI
31. Smith PM, Howitt MR, Panikov N, et al. The microbial metabolites, short-chain fatty acids, regulate colonic Treg cell homeostasis.
Science 2013;341:569-73. DOI PubMed PMC
32. Lautenschläger C, Schmidt C, Fischer D, Stallmach A. Drug delivery strategies in the therapy of inflammatory bowel disease. Adv
Drug Deliv Rev 2014;71:58-76. DOI PubMed
33. Yasmin F, Najeeb H, Shaikh S, et al. Novel drug delivery systems for inflammatory bowel disease. World J Gastroenterol
2022;28:1922-33. DOI PubMed PMC
34. Steidler L, Hans W, Schotte L, et al. Treatment of murine colitis by Lactococcus lactis secreting interleukin-10. Science
2000;289:1352-5. DOI PubMed
35. Steidler L, Neirynck S, Huyghebaert N, et al. Biological containment of genetically modified Lactococcus lactis for intestinal
delivery of human interleukin 10. Nat Biotechnol 2003;21:785-9. DOI
36. Braat H, Rottiers P, Hommes DW, et al. A phase I trial with transgenic bacteria expressing interleukin-10 in Crohn’s disease. Clin
Gastroenterol Hepatol 2006;4:754-9. DOI PubMed
37. Jiang R, Yuan S, Zhou Y, et al. Strategies to overcome the challenges of low or no expression of heterologous proteins in Escherichia
coli. Biotechnol Adv 2024;75:108417. DOI PubMed
38. Plotkin JB, Kudla G. Synonymous but not the same: the causes and consequences of codon bias. Nat Rev Genet 2011;12:32-42. DOI